Published in Gut on June 01, 2008
Asian consensus report on functional dyspepsia. J Neurogastroenterol Motil (2012) 1.09
Caecal pH is a biomarker of excessive colonic fermentation. World J Gastroenterol (2014) 1.09
Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther (2008) 1.06
Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol (2014) 1.00
Bloating in gastroparesis: severity, impact, and associated factors. Am J Gastroenterol (2011) 0.93
Functional dyspepsia: new insights into pathogenesis and therapy. Korean J Intern Med (2016) 0.92
Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air? Gastroenterol Hepatol (N Y) (2011) 0.91
Women's interpretation of and responses to potential gynaecological cancer symptoms: a qualitative interview study. BMJ Open (2015) 0.89
Abdominal bloating: pathophysiology and treatment. J Neurogastroenterol Motil (2013) 0.83
Health care seeking for abdominal bloating and visible distention. Aliment Pharmacol Ther (2009) 0.81
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial. PLoS One (2015) 0.80
Bloating and functional gastro-intestinal disorders: where are we and where are we going? World J Gastroenterol (2014) 0.80
An exploration of the barriers to the confident diagnosis of irritable bowel syndrome: A survey among general practitioners, gastroenterologists and experts in five European countries. United European Gastroenterol J (2015) 0.79
Functional abdominal bloating with distention. ISRN Gastroenterol (2012) 0.78
Are bloating and abdominal distention attributed to gas production and visceral sensitivity in irritable bowel syndrome? (Am j gastroenterol 2013;108:1516-1525). J Neurogastroenterol Motil (2013) 0.75
Clinical Dimensions of Bloating in Functional Gastrointestinal Disorders. J Neurogastroenterol Motil (2016) 0.75
Bloating in Iran: SEPAHAN Systematic Review No. 4. Int J Prev Med (2012) 0.75
Perilla extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study. BMC Complement Altern Med (2014) 0.75
History of the Rochester Epidemiology Project. Mayo Clin Proc (1996) 21.72
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63
Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
Functional gastroduodenal disorders. Gut (1999) 3.74
A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study. Am J Gastroenterol (2004) 3.11
Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med (1994) 3.02
Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut (1983) 2.93
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
WHO Study on the reliability and validity of the alcohol and drug use disorder instruments: overview of methods and results. Drug Alcohol Depend (1997) 2.59
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol (2003) 2.21
Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology (2007) 2.14
Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12
Ranking of symptoms by patients with the irritable bowel syndrome. BMJ (1989) 1.87
Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol (2004) 1.86
A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology (2005) 1.73
Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology (2006) 1.69
Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut (2001) 1.62
Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci (2000) 1.50
Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol (1999) 1.49
Associations between symptoms of irritable colon and psychological and social conditions and lifestyle. Br Med J (Clin Res Ed) (1986) 1.44
Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology (1992) 1.41
Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.41
Psychometric properties of the SUNYA revision of the Psychosomatic Symptom Checklist. J Behav Med (1984) 1.41
Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol (2001) 1.40
The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut (2002) 1.39
Gender differences in Manning criteria in the irritable bowel syndrome. Gastroenterology (1991) 1.34
Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study. Am J Gastroenterol (2000) 1.31
Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol (1999) 1.19
Antro-fundic dysfunctions in functional dyspepsia. Gastroenterology (2003) 1.16
Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterol (2003) 1.15
Prokinetic effects in patients with intestinal gas retention. Gastroenterology (2002) 1.14
Mechanisms of intestinal gas retention in humans: impaired propulsion versus obstructed evacuation. Am J Physiol Gastrointest Liver Physiol (2001) 1.12
Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil (2004) 1.11
Dietary fructose and gastrointestinal symptoms: a review. Am J Gastroenterol (2004) 1.10
Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut (1994) 1.07
A formal approach to symptoms in dyspepsia. Clin Gastroenterol (1985) 1.03
Impaired viscerosomatic reflexes and abdominal-wall dystony associated with bloating. Gastroenterology (2006) 1.02
A prospective study of unexplained visible abdominal bloating. N Z Med J (1994) 0.97
Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders. Neurogastroenterol Motil (2005) 0.94
Daily gastrointestinal symptoms in women with and without a diagnosis of IBS. Dig Dis Sci (1995) 0.92
Role of colonic fermentation in the perception of colonic distention in irritable bowel syndrome and functional bloating. Clin Gastroenterol Hepatol (2006) 0.91
Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut (2001) 0.89
Anxiety and depression in patients with abdominal bloating. Can J Psychiatry (1993) 0.84
Epidemiology of slow and fast colonic transit using a scale of stool form in a community. Aliment Pharmacol Ther (2007) 0.81
Expert commentary--bloating, distension, and the irritable bowel syndrome. MedGenMed (2005) 0.81
A device for 24 hour ambulatory monitoring of abdominal girth using inductive plethysmography. Physiol Meas (2002) 0.81
Hysterical type of nongaseous abdominal bloating. Arch Intern Med (Chic) (1949) 0.80
Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy. Eur J Gastroenterol Hepatol (2000) 0.78
Association of physical and emotional symptoms with the menstrual cycle and life-style. J Reprod Med (1993) 0.78
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med (1998) 5.67
Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66
Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62
Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60
Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59
Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16
A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology (1990) 4.02
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2001) 3.85
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81
Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology (2001) 3.60
A patient questionnaire to identify bowel disease. Ann Intern Med (1989) 3.43
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med (1997) 3.31
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology (1989) 3.12
Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00
Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology (1993) 2.99
The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82
Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81
Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther (2005) 2.71
Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67
Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A streptococci from throat swabs. J Clin Microbiol (2003) 2.57
Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology (1990) 2.56
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54
Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38
Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35
Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33
Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32
Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Outcomes after curative resections of cholangiocarcinoma. Arch Surg (1993) 2.26
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med (1982) 2.23
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22
Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology (1992) 2.17
Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17
Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population. Aliment Pharmacol Ther (2004) 2.13
Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.13
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology (1994) 2.12
Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil (2014) 2.11
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome. Gastroenterology (1990) 2.09
Severe exercise-induced ischemia does not identify high risk patients with normal left ventricular function and one- or two-vessel coronary artery disease. J Am Coll Cardiol (1994) 2.08
Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther (2014) 2.08
Prospective comparison of endoscopy patient satisfaction surveys: e-mail versus standard mail versus telephone. Am J Gastroenterol (2001) 2.08
The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05
Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut (2001) 2.05
What prognostic factors are important in duodenal adenocarcinoma? Arch Surg (2000) 2.03
Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol (1996) 2.01
The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01
Self-reported abuse and gastrointestinal disease in outpatients: association with irritable bowel-type symptoms. Am J Gastroenterol (1995) 1.99
Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96
Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol (1995) 1.94
Predictors of outcome after percutaneous endoscopic gastrostomy: a community-based study. Mayo Clin Proc (1992) 1.94
Lipoprotein analysis in the evaluation of chest pain in the emergency department. Mayo Clin Proc (1991) 1.92
Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms. Am J Gastroenterol (1998) 1.88
A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.85
Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol (2001) 1.85
Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84
MR imaging-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology (1990) 1.84
Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. Aliment Pharmacol Ther (2003) 1.84
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut (1988) 1.82
Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci (1995) 1.81
Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol (1985) 1.81